Literature DB >> 23995876

Which bowel preparation is best? Comparison of a high-fibre diet leaflet, daily microenema and no preparation in prostate cancer patients treated with radical radiotherapy to assess the effect on planned target volume shifts due to rectal distension.

S Yahya1, A Zarkar, E Southgate, P Nightingale, G Webster.   

Abstract

OBJECTIVE: We evaluated and compared a high-fibre diet leaflet, daily microenema and no preparation to establish how best to achieve consistent bowel preparation in prostate cancer patients being treated with radical radiotherapy.
METHODS: 3 cohorts of 10 patients had different dietary interventions: no bowel preparation, high-fibre diet information leaflet and daily microenemas. The available cone beam CT (CBCT) scans of each patient were used to quantify interfractional changes in rectal distension (measured using average cross-sectional area-CSA), prostate shifts relative to bony anatomy compared with that at CT planning scan and rates of geometric miss (i.e. shifts of ≥5 mm). 85 CBCT scans were available in the pre-leaflet cohort, 89 scans in the post-leaflet, and 89 scans in the post-enema group.
RESULTS: Mean rectal CSA in the post-enema group was reduced compared with both pre-leaflet (p=0.010) and post-leaflet values (p=0.031). The magnitude of observed mean prostate shifts was significantly reduced in the post-enema group compared with the pre-leaflet group (p=0.014). The proportion of scans showing geometric miss (i.e. shift >5 mm) in the post-enema group (31%) was significantly lower than in the pre-leaflet (62%, p<0.001) or post-leaflet groups (56%, p<0.001).
CONCLUSION: This study indicates microenema to be an effective measure to achieve reduction in rectal CSA, prostate shift and reduce geometric miss of ≥5 mm. A further prospective randomised study is advocated to validate the results. ADVANCES IN KNOWLEDGE: The use of microenema is effective in reducing prostate shift and rectal CSA, consequently decreasing the incidence of geographical miss.

Entities:  

Mesh:

Year:  2013        PMID: 23995876      PMCID: PMC3830438          DOI: 10.1259/bjr.20130457

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  24 in total

1.  Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI.

Authors:  A R Padhani; V S Khoo; J Suckling; J E Husband; M O Leach; D P Dearnaley
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-06-01       Impact factor: 7.038

2.  Target position variability throughout prostate radiotherapy.

Authors:  L A Dawson; K Mah; E Franssen; G Morton
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-12-01       Impact factor: 7.038

3.  Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy.

Authors:  M J Zelefsky; D Crean; G S Mageras; O Lyass; L Happersett; C C Ling; S A Leibel; Z Fuks; S Bull; H M Kooy; M van Herk; G J Kutcher
Journal:  Radiother Oncol       Date:  1999-02       Impact factor: 6.280

4.  Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer.

Authors:  Michele Stasi; Fernando Munoz; Claudio Fiorino; Massimo Pasquino; Barbara Baiotto; Piergiorgio Marini; Giuseppe Malinverni; Riccardo Valdagni; Pietro Gabriele
Journal:  Radiother Oncol       Date:  2006-09-07       Impact factor: 6.280

5.  Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy.

Authors:  Renaud de Crevoisier; Susan L Tucker; Lei Dong; Radhe Mohan; Rex Cheung; James D Cox; Deborah A Kuban
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-15       Impact factor: 7.038

6.  Prostate motion during standard radiotherapy as assessed by fiducial markers.

Authors:  J M Crook; Y Raymond; D Salhani; H Yang; B Esche
Journal:  Radiother Oncol       Date:  1995-10       Impact factor: 6.280

7.  Analysis of prostate and seminal vesicle motion: implications for treatment planning.

Authors:  C J Beard; P Kijewski; M Bussière; R Gelman; D Gladstone; K Shaffer; M Plunkett; P Castello; C N Coleman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-01-15       Impact factor: 7.038

8.  The impact of contouring uncertainty on rectal 3D dose-volume data: results of a dummy run in a multicenter trial (AIROPROS01-02).

Authors:  Franca Foppiano; Claudio Fiorino; Giovanni Frezza; Carlo Greco; Riccardo Valdagni
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-10-01       Impact factor: 7.038

9.  Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy.

Authors:  J C Roeske; J D Forman; C F Mesina; T He; C A Pelizzari; E Fontenla; S Vijayakumar; G T Chen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-12-01       Impact factor: 7.038

10.  Appropriate patient instructions can reduce prostate motion.

Authors:  Reinhold Graf; Dirk Boehmer; Jacek Nadobny; Volker Budach; Peter Wust
Journal:  Radiat Oncol       Date:  2012-08-01       Impact factor: 3.481

View more
  9 in total

1.  Effect of magnesium oxide on interfraction prostate motion and rectal filling in prostate cancer radiotherapy: analysis of a randomized clinical trial.

Authors:  Annemarie M den Harder; Carla H van Gils; Alexis N T J Kotte; Marco van Vulpen; Irene M Lips
Journal:  Strahlenther Onkol       Date:  2014-04-24       Impact factor: 3.621

2.  Bowel and Bladder Reproducibility in Image Guided Radiation Therapy for Prostate Cancer: Results of a Patterns of Practice Survey.

Authors:  Lindsay S Rowe; Jeremy J Mandia; Kilian E Salerno; Uma T Shankavaram; Shaoli Das; Freddy E Escorcia; Holly Ning; Deborah E Citrin
Journal:  Adv Radiat Oncol       Date:  2022-02-03

3.  Advantages of Radiation Therapy Simulation with 0.35 Tesla Magnetic Resonance Imaging for Stereotactic Ablation of Spinal Metastases.

Authors:  Benjamin Spieler; Stuart E Samuels; Ricardo Llorente; Raphael Yechieli; John Chetley Ford; Eric A Mellon
Journal:  Pract Radiat Oncol       Date:  2019-11-26

4.  Proctitis 1 Week after Stereotactic Body Radiation Therapy for Prostate Cancer: Implications for Clinical Trial Design.

Authors:  Ima Paydar; Robyn A Cyr; Thomas M Yung; Siyuan Lei; Brian Timothy Collins; Leonard N Chen; Simeng Suy; Anatoly Dritschilo; John H Lynch; Sean P Collins
Journal:  Front Oncol       Date:  2016-07-20       Impact factor: 6.244

Review 5.  ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.

Authors:  Nicholas G Zaorsky; Timothy N Showalter; Gary A Ezzell; Paul L Nguyen; Dean G Assimos; Anthony V D'Amico; Alexander R Gottschalk; Gary S Gustafson; Sameer R Keole; Stanley L Liauw; Shane Lloyd; Patrick W McLaughlin; Benjamin Movsas; Bradley R Prestidge; Al V Taira; Neha Vapiwala; Brian J Davis
Journal:  Adv Radiat Oncol       Date:  2016-10-20

Review 6.  Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target Concept.

Authors:  Florent Vilotte; Mickael Antoine; Maxime Bobin; Igor Latorzeff; Stéphane Supiot; Pierre Richaud; Laurence Thomas; Nicolas Leduc; Stephane Guérif; Jone Iriondo-Alberdi; Renaud de Crevoisier; Paul Sargos
Journal:  Front Oncol       Date:  2017-03-09       Impact factor: 6.244

7.  Role of non-absorbable oral antibiotics in bowel preparation for intracavitary brachytherapy: effects of rifaximin on rectal dosimetric parameters during vaginal cuff brachytherapy.

Authors:  Sasan Razmjoo; Ali Bagheri; Hodjatollah Shahbazian; Seyed-Mohammad Hosseini; Faezeh Ebrahimian-Tabrizi
Journal:  J Contemp Brachytherapy       Date:  2021-08-24

Review 8.  ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II.

Authors:  Nicholas G Zaorsky; Timothy N Showalter; Gary A Ezzell; Paul L Nguyen; Dean G Assimos; Anthony V D'Amico; Alexander R Gottschalk; Gary S Gustafson; Sameer R Keole; Stanley L Liauw; Shane Lloyd; Patrick W McLaughlin; Benjamin Movsas; Bradley R Prestidge; Al V Taira; Neha Vapiwala; Brian J Davis
Journal:  Adv Radiat Oncol       Date:  2017-03-20

9.  Voxel-based supervised machine learning of peripheral zone prostate cancer using noncontrast multiparametric MRI.

Authors:  Neda Gholizadeh; John Simpson; Saadallah Ramadan; Jim Denham; Peter Lau; Sabbir Siddique; Jason Dowling; James Welsh; Stephan Chalup; Peter B Greer
Journal:  J Appl Clin Med Phys       Date:  2020-08-08       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.